Olopatadine: a drug for allergic conjunctivitis targeting the mast cell. - Wikidata - wikimedia - TriplyDB

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

http://www.wikidata.org/entity/Q37716013

about

Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management The expanding role of H1 antihistamines: a patent survey of selective and dual activity compounds 2005-2010.Effects of Angelica acutiloba on mast cell-mediated allergic reactions in vitro and in vivo.Determination of olopatadine in human tears by hydrophilic interaction liquid chromatography-MS/MS method.

P2860

Q26771818-FFEBA8F5-6623-4E5A-B77F-54516088C142 Q37780551-C2213D8E-1583-4B3D-924F-90511E9A3859 Q39435405-FD6730C2-BA1A-4ECA-BAF5-759BB5F5534A Q47769592-E1ED9277-6C3D-4790-9DCE-C820BF60AC2E

P2860

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

http://www.wikidata.org/entity/Q37716013

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

@en

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

@nl

type

label

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

@en

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

@nl

prefLabel

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

@en

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

@nl

P1433

Q37716013-F4B3DCCA-34E2-4155-BE7C-81F3D73C40E2

P1476

Q37716013-E1A21300-23D0-494C-8643-A3E1F2E3B2E9

P2093

Q37716013-AA43A318-115A-47DE-9FF5-5277BBF90450

P2860

Q37716013-04974D81-6528-403F-B902-49850FA39463

Q37716013-0D41BB1B-5E88-4A6A-B37D-10829E92AFFE

Q37716013-1D1A4C55-9B79-4703-B598-5DA8CD9E3767

Q37716013-1E6079B1-754B-41D0-B8C5-2EB024EB1BA6

Q37716013-2AED24CF-2E49-43FD-BC0F-1D33B818F9C6

Q37716013-2B734ED2-3317-4F9A-AA80-2F6AC87929F0

Q37716013-2BD18C20-12A7-4F3D-A827-2F1B92D7A65C

Q37716013-2F276FA8-37CC-41BD-B84C-E6545AFB906C

Q37716013-32AF8C1B-7C33-4E77-BCFA-C17AF8428130

Q37716013-37765650-6B0F-40F6-9BEC-099E04451FE0

P304

Q37716013-262C7E9E-B51E-41D0-8550-3C0796F3AEAC

P31

Q37716013-B1E3BBDF-6BFD-439A-95CA-3DF9062702D7

P356

Q37716013-E9061A4C-C345-4DDD-A6B3-FE9C0E61012A

P407

Q37716013-A77F6756-D9D7-4402-895C-95B281994235

P433

Q37716013-3EEC2A32-D452-4686-A18F-1701D5472B1E

P478

Q37716013-323871B2-1938-4CDE-8FBD-E647C32A5CC4

P50

Q37716013-0A761280-4247-4A07-8465-C6A05E6734C4

P577

Q37716013-86A0951E-42CE-4D3E-99B0-DABCDA86C201

P698

Q37716013-6454B224-8B46-4044-9674-8B13042FB3D9

P921

Q37716013-CDEFE4B2-578A-497C-8FF2-00F6D2E3B719

P356

14656561003694643

P1433

Expert Opinion on Pharmacotherapy

P1476

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell

@en

P2093

Andrea Leonardi

http://www.w3.org/2001/XMLSchema#string

P2860

Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions

Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils

One-visit, randomized, placebo-controlled, conjunctival allergen challenge study of scanning and imaging technology for objective quantification of eyelid swelling in the allergic reaction with contralateral use of olopatadine and artificial tears.

Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: a post hoc analysis of data from a conjunctival allergen challenge study.

Allergy and allergic diseases. First of two parts.

Neural integration and allergic disease.

Allergic conjunctivitis: update on pathophysiology and prospects for future treatment.

Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity.

Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research.

Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs.

P304

969-981

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656561003694643

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Luigi Quintieri

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20307221

http://www.w3.org/2001/XMLSchema#string

P921